Navigation Links
Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
Date:2/6/2008

Effort is Launched With UC Davis Collaboration

RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury, today announced a regenerative medicine initiative in the veterinary market.

The Company has created a wholly-owned subsidiary, Vantus, Inc., a veterinary stem cell laboratory services company. The Company is in the process of completing a research collaboration with the Center for Equine Health and Stem Cell Regenerative Medicine Group at the University of California, Davis, School of Veterinary Medicine.

Under the collaboration, the Company's MarrowXpress(TM) System and BioArchive(R) System will be used for the processing and cryogenic storage of equine stem cells from cell rich sources, including fetal tissue and fluids during foaling, and bone marrow from yearlings and adults. The stem cells will be used in therapeutic treatment of orthopedic injuries in the performance equine market including Thoroughbreds, American Quarter Horses, and Arabians. The Company is currently refining collection and processing methodologies at large breeder farms in California, and expects to be in operation commencing with the 2009 foaling season, which begins in January of next year.

"The creation of Vantus, Inc. is a major milestone in our regenerative medicine diversification strategy that we began implementing several months ago. This program leverages the expertise and world renowned reputation of the UC Davis organization in animal research and our industry leading stem cell processing and storage technologies," noted Dr. William Osgood, Chief
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Corp. Reports First Quarter 2008 Results
2. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
3. Zipfizz(R) Announces Expanded Distribution
4. Mangrove Announces Health Savings Account (HSA) and Health Reimbursement Account (HRA) Product Launches
5. Senetek PLC Announces Launch of New Website
6. Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
7. Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008
8. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
9. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
10. The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationwi... Yasmin birth control pills who have suffered a De...ke, Heart Attack or other related cardiac issues o...ll free at 1-800-856-6405 or go to the firm’...t an online case evaluation form. , ...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...dsoftwareandCalgaryScientificInc.,aleadingprovider...ersionofAegis(TM)Breast4DAdvancedVisualizationsoft...zero-footprintWebclientbasedmedicalimagingoffering...allowsforzero-footprintaccess-requiringnosoftwared...
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... studies on subject, researchers note , , ...been enough studies to tell whether aspirin reduce...th the blocked leg blood vessel condition called p...studies of aspirin use with peripheral arterial di...
...ear-old Alexander, it,s meant orthotics and physic... For 7-year-old Rebecca, it,s an insulin pump for ...o has cerebral palsy, it,s a wheelchair. , , All ... help pay for desperately needed medical care or e...
...e More Informed Decisions When Choosing Nutritiona...ews stories on steroid use in sports continue to e...ements and sports nutrition products for banned su...o protecting and improving public health, has laun...
...s and experts will gather in New Orleans on June 1...ealth and property damage controversy involving bu...hey also are gathering for two teleconferences dea...least 13 states and the District of Columbia have ...
... posed by other strains of influenza, CDC says , ...health officials said Tuesday that they,re seeing ...ne flu continues to spread across the country. , "... severe complications in women with this year,s no...
...sTek, the leader in innovative electronic patient ...tion for clinical trials has continued its investm...ssisTek,s ongoing development of Smart Phone and e...9 -- assisTek, the leader in innovative electroni...
Other Medicine News:Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:New Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned Substances 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 3
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2
...EY HEIGHTS, NJ – June 4, 2007 – Genta,...tion of results,from a Phase 2 clinical trial of i...injection), plus rituximab (Rituxan®;,Genentec...d or,refractory non-Hodgkin’s lymphoma (NHL)... the American Society of Clinical,Oncology (ASCO) ...
...O--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therape...cal collaborators today,reported updated Phase 2 d...n abnormal p53, tumor responses and increased,surv... recurrent,squamous cell carcinoma of the head and...day at the annual meeting of the American,Society ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
LabDAQ3 Laboratory Information System
...ies to work more efficiently has never been higher...th the COBAS INTEGRA® 400 plus, innovation mea...ndling of reaction cuvettes and improved operator ...ease-of-use required for true workload consolidati...
...ng a non-contact diagnostic lens, doctors have to ...gh magnification. Now, with the Digital Wide Fiel...n have both in one lens. This lens provides the w...s paired with the higher magnification required fo...
...Anchor is a unique double loaded anchor perfect fo...y-L Lactic Acid (PLLA) and comes in two sizes: 5.0...nds for open repairs, and can easily be cut-off fo...lows insertion with minimal procedural steps and t...
Medicine Products: